2013Journal of Clinical Pulmonary MedicineRequires access

Observation of clinical efficacy of piperacillin-tazobactam in the treatment of elderly patients with hospital-acquired pneumonia

Zheng Wen

Open publisher page 1 citations

Abstract

Objective To evaluate the efficacy of piperacillin-tazobactam in the treatment of elderly patients with hospital-acquired pneumonia.Methods 65 elderly patients with hospital-acquired pneumonia were randomly divided into the piperacillin-tazobactam group(n=33) and the cefoperazone-sulbactam group(n=32).The clinical efficacy was evaluated and the susceptibility test of isolated bacteria from sputum cluture was made between the two groups.Results The total effective rates were 87.8% and 71.8% and bacterial eradication rates were 82.6 and 76.4% respectively in the piperacillin-tazobactam group and the cefoperazone-sulbactam group with significant differences(P0.05).Conclusion Piperacillin-tazobactam is effective in the treatment of elderly patients with hospital-acquired pneumonia with good antibiotic activity in vitro.

About this research paper

What this paper is about

Objective To evaluate the efficacy of piperacillin-tazobactam in the treatment of elderly patients with hospital-acquired pneumonia.Methods 65 elderly patients with hospital-acquired pneumonia were randomly divided into the piperacillin-tazobactam group(n=33) and the cefoperazone-sulbactam group(n=32).The clinical efficacy was evaluated and the susceptibility test of isolated bacteria from sputum cluture was made between the two groups.Results The total effective rates were 87.8% and 71.8% and bacterial eradication rates were 82.6 and 76.4% respectively in the piperacillin-tazobactam group and the cefoperazone-sulbactam group with significant differences(P0.05).Conclusion Piperacillin-tazobactam is effective in the treatment of elderly patients with hospital-acquired pneumonia with good antibiotic activity in vitro.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the efficacy of piperacillin-tazobactam in the treatment of elderly patients with hospital-acquired pneumonia.Methods 65 elderly patients with hospital-acquired pneumonia were randomly divided into the piperacillin-tazobactam group(n=33) and the cefoperazone-sulbactam group(n=32).The clinical efficacy was evaluated and the susceptibility test of isolated bacteria from sputum cluture was made between the two groups.Results The total effective rates were 87.8% and 71.8% and bacterial eradication rates were 82.6 and 76.4% respectively in the piperacillin-tazobactam group and the cefoperazone-sulbactam group with significant differences(P0.05).Conclusion Piperacillin-tazobactam is effective in the treatment of elderly patients with hospital-acquired pneumonia with good antibiotic activity in vitro.

Key concepts: Medicine, Piperacillin/tazobactam, Tazobactam, Sulbactam, Piperacillin, Cefoperazone, Hospital-acquired pneumonia, Pneumonia

Related papers

Back to paper searchBrowse research topicsOriginal source
Observation of clinical efficacy of piperacillin-tazobactam in the treatment of elderly patients with hospital-acquired pneumonia — Research Paper | ScholarLens